VERNERO, MARTA
 Distribuzione geografica
Continente #
NA - Nord America 1.326
EU - Europa 647
AS - Asia 366
SA - Sud America 33
OC - Oceania 22
AF - Africa 20
Continente sconosciuto - Info sul continente non disponibili 7
Totale 2.421
Nazione #
US - Stati Uniti d'America 1.294
IT - Italia 221
CN - Cina 162
IE - Irlanda 82
SE - Svezia 56
ES - Italia 54
GB - Regno Unito 49
IN - India 48
JP - Giappone 37
VN - Vietnam 30
DE - Germania 28
CA - Canada 26
FR - Francia 26
BR - Brasile 23
TR - Turchia 20
HK - Hong Kong 19
AU - Australia 16
PL - Polonia 16
CH - Svizzera 15
NL - Olanda 15
UA - Ucraina 14
FI - Finlandia 12
BE - Belgio 11
KR - Corea 11
SG - Singapore 9
CZ - Repubblica Ceca 8
IL - Israele 7
PT - Portogallo 7
AT - Austria 6
CO - Colombia 6
NZ - Nuova Zelanda 6
EU - Europa 5
ID - Indonesia 5
TW - Taiwan 5
BA - Bosnia-Erzegovina 4
EG - Egitto 4
MX - Messico 4
RU - Federazione Russa 4
CL - Cile 3
DK - Danimarca 3
DZ - Algeria 3
HR - Croazia 3
HU - Ungheria 3
IR - Iran 3
KE - Kenya 3
NG - Nigeria 3
NO - Norvegia 3
PS - Palestinian Territory 3
SA - Arabia Saudita 3
SN - Senegal 3
AP - ???statistics.table.value.countryCode.AP??? 2
MA - Marocco 2
RO - Romania 2
BD - Bangladesh 1
BG - Bulgaria 1
CU - Cuba 1
FO - Isole Faroe 1
GR - Grecia 1
GT - Guatemala 1
KW - Kuwait 1
LB - Libano 1
LT - Lituania 1
PE - Perù 1
RS - Serbia 1
TH - Thailandia 1
TN - Tunisia 1
ZM - Zambia 1
Totale 2.421
Città #
Ann Arbor 286
Fairfield 102
Dublin 81
Chandler 72
Redwood City 63
Houston 58
Ashburn 57
Wilmington 47
Woodbridge 47
Torino 45
Cambridge 39
Seattle 39
Beijing 37
Turin 37
Jacksonville 35
Nyköping 27
Dong Ket 22
Medford 21
Princeton 19
Barcelona 18
Pisa 18
Hangzhou 14
Washington 14
Guangzhou 13
San Diego 13
Shanghai 13
Dearborn 12
Nanjing 11
Warsaw 11
Villeurbanne 8
Chengdu 7
Duncan 7
Los Angeles 7
New York 7
Tokyo 7
Boston 6
Central District 6
Hebei 6
Helsinki 6
Hyderabad 6
Indore 6
Milan 6
Newbury Park 6
San Francisco 6
Santa Lucia di Piave 6
Upper Marlboro 6
Vienna 6
Jakarta 5
Jinan 5
Lappeenranta 5
Norwalk 5
Ottawa 5
Padova 5
Rome 5
Seoul 5
Amsterdam 4
Boardman 4
Breda 4
Castellar 4
Central 4
Crescentino 4
Izmir 4
Medellín 4
Santa Clara 4
Shinjuku 4
Toronto 4
Zhengzhou 4
Bronx 3
Brussels 3
Cairo 3
Calgary 3
Campo Grande 3
Catania 3
Changchun 3
Changsha 3
Chiloeches 3
Cleveland 3
Dengzhou 3
Frankfurt am Main 3
Fuzhou 3
Grugliasco 3
Istanbul 3
London 3
Madrid 3
Montreal 3
Paris 3
Perth 3
Pittsburgh 3
Prague 3
Riyadh 3
São Paulo 3
Taipei 3
Utrecht 3
Valencia 3
Vigo 3
Welwyn Garden City 3
Wuhan 3
Zhangjiagang 3
Abuja 2
Ankara 2
Totale 1.571
Nome #
The adherence to the therapy in inflammatory bowel disease: beyond the number of the tablets 319
Effectiveness and safety of adalimumab biosimilar ABP 501 in Crohn's disease: an observational study 280
Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy 214
Risk of incident melanoma in patients with inflammatory disease treated with anti-TNF: the Turin experience 194
OC. 12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION 130
How ameliorate the adherence in patients with inflammatory bowel disease? 126
Dual biological therapy with anti-TNF, vedolizumab or ustekinumab in inflammatory bowel disease: a systematic review with pool analysis 126
Targeting IL-10, ZO-1 gene expression and IL-6/STAT-3 trans-signalling by a combination of atorvastatin and mesalazine to enhance anti-inflammatory effects and attenuate progression of oxazolone-induced colitis 121
Helicobacter pylori prevalence: Are the data totally reliable? 106
THE ROLE OF ANTI-IFI16 ANTIBODIES IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES (IBD) 103
The Usefulness of Microencapsulated Sodium Butyrate Add-On Therapy in Maintaining Remission in Patients with Ulcerative Colitis: A Prospective Observational Study 94
New Onset of Inflammatory Bowel Disease in Three Patients Undergoing IL-17A Inhibitor Secukinumab: A Case Series 86
P21 | Oral Iron Supplementation with Iron Bisglycinate Chelate in Inflammatory Bowel Disease: A Retrospective Observational Study 82
Oral iron supplementation with Feralgine® in inflammatory bowel disease: a retrospective observational study 63
Risk Factors of Urothelial Cancer in Inflammatory Bowel Disease 63
Inflammatory Bowel Disease Nurse—Practical Messages 62
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS-CoV-2 infection: an IG-IBD study 60
Switching from Biosimilar to Biosimilar Adalimumab, Including Multiple Switching, in Crohn's Disease: A Prospective Study 56
Insights into the role of gastrointestinal ultrasound in ulcerative colitis 48
Expression of SARS-Cov-2 Entry Factors in Patients with Chronic Hepatitis 24
Periodontitis Prevalence and Severity in Inflammatory Bowel Disease: A Case-Control Study 22
Cancer Risk in Patients Treated with the JAK Inhibitor Tofacitinib: Systematic Review and Meta-Analysis 16
Determinants and Trends of Adherence to a Gluten-Free Diet in Adult Celiac Patients on a Long-term Follow-up (2000-2020) 16
Possible Impact of Vitamin D Status and Supplementation on SARS-CoV-2 Infection Risk and COVID-19 Symptoms in a Cohort of Patients with Inflammatory Bowel Disease 15
Reduced humoral response to two doses of COVID-19 vaccine in patients with inflammatory bowel disease: Data from ESCAPE-IBD, an IG-IBD study 12
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 11
Artificial intelligence in gastrointestinal endoscopy for inflammatory bowel disease: a systematic review and new horizons 10
The recipe for the perfect inflammatory bowel disease nurse in a northern Italy tertiary IBD center: going beyond clinical care 9
Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease 9
Pitfalls in the Diagnosis of Coeliac Disease and Gluten-Related Disorders 7
Inflammatory bowel disease and immune-mediated inflammatory diseases: looking at the less frequent associations 7
Efficacy and Safety of Adalimumab Biosimilar GP2017 in Patients with Inflammatory Bowel Disease 7
Prevalence and Clinical Impact of Immune-Mediated Inflammatory Diseases in Patients with Inflammatory Bowel Disease: Results from a Large Retrospective Observational Study 6
Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission: The SVEDO Study, an IG-IBD study 5
Prevalence of Multiple Sclerosis in Patients with Inflammatory Bowel Disease 5
The GLU-10: a validated ten-point score to identify poorly instructed celiac patients in need of dietary interventions 5
Correlation between Polymorphisms of Vitamin D Metabolism Genes and Perianal Disease in Crohn’s Disease 4
Anti-IL23 in inflammatory bowel disease patients with dermatological indication: The shared gastroenterological-dermatological clinic experience 4
Analytical and clinical comparison of different immunoassay systems for the detection of antiphospholipid antibodies 3
Vigorous Physical Activity as a Risk Factor for Central Serous Chorioretinopathy 1
Immune-Mediated Inflammatory Diseases Awareness and Management among Physicians Treating Patients with Inflammatory Bowel Disease: An IG-IBD Survey 1
Totale 2.532
Categoria #
all - tutte 7.360
article - articoli 0
book - libri 0
conference - conferenze 822
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.182


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201954 0 0 0 0 0 0 0 0 0 0 36 18
2019/2020387 19 11 18 31 17 27 31 49 53 59 31 41
2020/2021404 29 27 34 19 25 72 26 23 27 40 22 60
2021/2022640 34 27 29 33 20 37 133 119 87 21 46 54
2022/2023419 47 27 14 30 29 85 57 29 37 18 28 18
2023/2024454 49 65 46 39 54 50 44 43 15 43 6 0
Totale 2.532